#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA5100323	B	Inhibition of N-terminal His-Avi tagged recombinant human FGFR3 (447 to 761 residues) expressed in an Sf9 infected baculovirus expression system using biotin-EQEDEPEGDYFEWLE-amide as substrate preincubated for 5 to 10 mins followed by substrate addition and measured after 1 hr by HTRF assay	Homo sapiens	30		cell-based format	Scientific Literature
2.	ALA5100325	B	Inhibition of recombinant human FGFR1 using biotin-EQEDEPEGDYFEWLE-amide as substrate preincubated for 5 to 10 mins followed by substrate addition and measured after 1 hr by HTRF assay	Homo sapiens	29		single protein format	Scientific Literature
3.	ALA5100327	B	Inhibition of TEL-FGFR3 in mouse BaF3 cells incubated for 125 mins by plate reader analysis	Mus musculus	14		cell-based format	Scientific Literature
4.	ALA5100328	B	Inhibition of wild type partial length human FLT3 (V592 to Y969 residues) expressed in bacterial expression system using Ulight-p70S6K peptide substrate incubated for 90 mins in presence of ATP by HTRF assay	Homo sapiens	8		assay format	Scientific Literature
5.	ALA5100329	B	Inhibition of wild type partial length human TRKA (G475 to G790 residues) expressed in mammalian expression system using Ulight-p70S6K peptide substrate incubated for 90 mins in presence of ATP by HTRF assay	Homo sapiens	8		assay format	Scientific Literature
6.	ALA5100330	B	Inhibition of wild type partial length human KIT (I571 to D952 residues) expressed in bacterial expression system using Ulight-p70S6K peptide substrate incubated for 90 mins in presence of ATP by HTRF assay	Homo sapiens	8		assay format	Scientific Literature
7.	ALA5100331	B	Inhibition of wild type partial length human PDGFRbeta (V582 to Y1009 residues) expressed in bacterial expression system using Ulight-p70S6K peptide substrate incubated for 90 mins in presence of ATP by HTRF assay	Homo sapiens	8		assay format	Scientific Literature
8.	ALA5100332	A	Apparent permeability in human Caco-2 cells at 50 uM incubated for 120 mins by LC-MS/MS analysis	Homo sapiens	5		cell-based format	Scientific Literature
9.	ALA5100333	A	Metabolic stability in human liver microsomes assessed as clearance at 1 uM preincubated for 2 mins followed by NADPH addition and measured upto 30 mins by LC-MS/MS analysis	Homo sapiens	4		microsome format	Scientific Literature
10.	ALA5100334	P	Solubility of compound in FaSSIF by HPLC assay		3		small-molecule physicochemical format	Scientific Literature
11.	ALA5100335	P	Solubility of compound in SGF by HPLC assay		3		small-molecule physicochemical format	Scientific Literature
12.	ALA5100336	B	Inhibition of human liver microsomes CYP3A4 using midazolam or testosterone as substrate in presence of NADPH regenerating system by LC-MS/MS analysis	Homo sapiens	6		microsome format	Scientific Literature
13.	ALA5100337	A	Clearance in Sprague-Dawley rat assessed as hepatic blood flow at 0.73 mg/kg, iv measured upto 24 hrs by LC-MS/MS analysis	Rattus norvegicus	2		organism-based format	Scientific Literature
14.	ALA5100338	A	Volume of distribution at steady state in Sprague-Dawley rat at 0.73 mg/kg, iv measured upto 24 hrs by LC-MS/MS analysis	Rattus norvegicus	2		organism-based format	Scientific Literature
15.	ALA5100339	A	Half life in Sprague-Dawley rat at 0.73 mg/kg, iv measured upto 24 hrs by LC-MS/MS analysis	Rattus norvegicus	2		organism-based format	Scientific Literature
16.	ALA5100340	A	Cmax in Sprague-Dawley rat at 3.1 mg/kg, po measured upto 24 hrs by LC-MS/MS analysis	Rattus norvegicus	2		organism-based format	Scientific Literature
17.	ALA5100341	A	AUC in Sprague-Dawley rat at 3.1 mg/kg, po measured upto 24 hrs by LC-MS/MS analysis	Rattus norvegicus	2		organism-based format	Scientific Literature
18.	ALA5100342	A	Oral bioavailability in Sprague-Dawley rat at 3.1 mg/kg measured upto 24 hrs by LC-MS/MS analysis	Rattus norvegicus	2		organism-based format	Scientific Literature